NANOBIOTIX Reports H1 Basic EPS Of €(0.46), Up From €(0.80) Last Year, Revenue And Other Income Of €9.3M, Up From €3.3M Last Year
Portfolio Pulse from Benzinga Newsdesk
Nanobiotix reported a significant improvement in its financial performance for the first half of 2024, with a reduced net loss and increased revenue compared to the same period last year.
September 18, 2024 | 8:24 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Nanobiotix reported a reduced net loss and increased revenue for H1 2024. The basic EPS improved from €(0.80) to €(0.46), and revenue rose from €3.3M to €9.3M.
The improvement in EPS from €(0.80) to €(0.46) and the increase in revenue from €3.3M to €9.3M indicate a positive financial trend for Nanobiotix. This could lead to a positive short-term impact on the stock price as investors may view the company's financial health as improving.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100